Cargando…
Synergistic inhibition effect of TNIK inhibitor KY-05009 and receptor tyrosine kinase inhibitor dovitinib on IL-6-induced proliferation and Wnt signaling pathway in human multiple myeloma cells
Multiple myeloma is a fetal form of plasma cell malignancy characterized by abnormal clonal proliferation of plasma cells. Especially, the canonical Wnt signaling pathway mediated by β-catenin is activated in multiple myeloma cells, stimulating their proliferation. Here, we investigated the relation...
Autores principales: | Lee, Yura, Jung, Jung-Il, Park, Kyeong-Yong, Kim, Soon Ae, Kim, Jiyeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522218/ https://www.ncbi.nlm.nih.gov/pubmed/28467797 http://dx.doi.org/10.18632/oncotarget.17056 |
Ejemplares similares
-
A Receptor Tyrosine Kinase Inhibitor, Dovitinib (TKI-258), Enhances BMP-2-Induced Osteoblast Differentiation In Vitro
por: Lee, Yura, et al.
Publicado: (2016) -
A Novel Aminothiazole KY-05009 with Potential to Inhibit Traf2- and Nck-Interacting Kinase (TNIK) Attenuates TGF-β1-Mediated Epithelial-to-Mesenchymal Transition in Human Lung Adenocarcinoma A549 Cells
por: Kim, Jiyeon, et al.
Publicado: (2014) -
Emergence of TNIK inhibitors in cancer therapeutics
por: Yamada, Tesshi, et al.
Publicado: (2017) -
Interaction Potential of the Multitargeted Receptor Tyrosine Kinase Inhibitor Dovitinib with Drug Transporters and Drug Metabolising Enzymes Assessed in Vitro
por: Weiss, Johanna, et al.
Publicado: (2014) -
TNIK Inhibition Has Dual Synergistic Effects on Tumor and Associated Immune Cells
por: Kim, Jaehee, et al.
Publicado: (2022)